IBM Trades at Discount But Faces Investor Scrutiny Ahead of Q3 Earnings

International Business Machines (NYSE: IBM) is presenting a mixed picture for investors, with solid underlying financials offset by market skepticism and a challenging technical setup ahead of its third-quarter earnings release on October 21.

Fundamentals Show Strength and Strain

IBM's financial health has steadily improved over the last five years, according to figures cited by Investing.com. The company's revenue grew from $57.35 billion in fiscal 2021 to $67.53 billion in fiscal 2025, while its EBITDA expanded by 43% to $16.17 billion over the same period. This growth has been driven by a strategic shift toward higher-margin software and services, lifting gross margins to 58.2%.

Key financial metrics underscore the company's operational strength, including a robust $13.79 billion in free cash flow and a high return on equity (ROE) of 34.6%. However, a significant point of concern is the company's leverage, with a debt-to-equity ratio of 189.5%, largely a result of major acquisitions like Red Hat.

A Pattern of Post-Earnings Weakness

Despite a history of beating earnings per share (EPS) estimates, IBM's stock has often reacted negatively, pointing to deeper investor concerns. Following its Q1 2026 earnings beat, for example, the stock fell 9.62% as the market focused on softness in the consulting business, a key component of IBM's AI-services narrative.

This sentiment is reflected in a divided analyst community. Bullish firms like Oppenheimer (target $350) point to the potential of the Watsonx AI platform and a quantum computing valuation of $65 per share. In contrast, bears like HSBC (target $191) argue the stock is overvalued compared to faster-growing peers.

Ad

Technicals Signal Near-Term Caution

Technical indicators are flashing warning signs for IBM's stock. As of September 21, both the daily and weekly charts registered "Strong Sell" signals, according to the source analysis. The stock is trading below all its short-term moving averages, and a bearish "Three Outside Down" candlestick pattern has emerged on the weekly chart, suggesting a potential reversal.

Key price levels for traders to watch include immediate support at $226.65 and a more significant weekly support zone at $214.49. On the upside, resistance is found near $235.16, a level the stock would need to reclaim to shift the negative short-term momentum.

What to Watch on October 21

IBM's upcoming earnings report is the next major catalyst for the stock. Wall Street consensus estimates are for an EPS of $2.88 on revenue of $16.82 billion. Investors will be closely monitoring three key areas:

• Watsonx and AI Bookings: Progress toward a targeted $12.5 billion milestone is crucial to validating the bull case.
• Consulting Segment Performance: Any signs of stabilization or recovery in this division could spark a relief rally.
• Quantum Roadmap Updates: Concrete news on the company's goal of achieving fault-tolerant quantum computing by 2029 could reinforce its long-term value proposition.